Symbol
aTyr Pharma, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$2.79
Current price of the stock
$1M
Trading volume of the stock
$211.5M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
4.86
Mean analyst rating
575.02%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.02
Total debt to total equity ratio
5.41
Current ratio
-
Gross profit margin
-
Operating profit margin
-
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-
Pretax profit margin
-
Net profit margin
-26.50%
Measures profitability relative to shareholders' equity
-26.50%
ROE excluding intangible assets
-18.84%
Measures profitability relative to total assets
-26.09%
Measures profitability relative to invested capital
-
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-3.03
Measures valuation relative to earnings
-
P/E based on future earnings estimates
899.94
Measures valuation relative to sales
3.25
Measures valuation relative to book value
-1.22
Measures valuation relative to operating cash flow
-1.18
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
